Comparison of uric acid reduction and renal outcomes of febuxostat vs allopurinol in patients with chronic kidney disease

Whether the clinical trial treatment effect of urate-lowering therapy (ULT) in patient with chronic kidney disease (CKD) is generalizable to real-word settings is unclear. This study aimed to compare febuxostat with allopurinol for uric acid reduction and renal protection in patients with CKD. Adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yueh-Lung, Tain, You-Lin, Lee, Chien-Te, Yang, Yi-Hsn, Huang, Yaw-Bin, Wen, Yen-Hsia, Hsu, Chien-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329906/
https://www.ncbi.nlm.nih.gov/pubmed/32612180
http://dx.doi.org/10.1038/s41598-020-67026-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329906/
https://www.ncbi.nlm.nih.gov/pubmed/32612180
http://dx.doi.org/10.1038/s41598-020-67026-1

Ejemplares similares